<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02813512</url>
  </required_header>
  <id_info>
    <org_study_id>CMUH102-REC1-034</org_study_id>
    <nct_id>NCT02813512</nct_id>
  </id_info>
  <brief_title>Clinical Trial Study About Human Adipose-Derived Stem Cells in the Stroke</brief_title>
  <official_title>Adipose-Derived Stem Cells (ADSCs) Injections for Stroke</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Gwo Xi Stem Cell Applied Technology Co., Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Gwo Xi Stem Cell Applied Technology Co., Ltd.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of the study is to confirm the safety and possible efficacy of Adipose-Tissue
      Derived Stem Cells treatment of chronic stroke. Specifically, the study will transplant
      autologous ADSCs into brain surrounding ischemic infarct in adult (65-80 years old) subjects
      who have chronic non-hemorrhagic stroke (&gt;6 months).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This open-label clinical trial will compare outcomes of subjects with chronic stroke. Six
      subjects will be to treatment (n=3) groups. The treatment group will receive brain
      transplants of autologous ADSCs. Treatment group will receive rehabilitation after the
      transplantation. Subjects will be assessed by magnetic resonance imaging (MRI) and eight
      standardized stroke indices: National Institutes of Health Stroke Scale (NIHSS), ( Barthel
      Index )、 ( Berg balance scale )、 (Fugl - Meyer test )、(Action research arm test )、 (Purdue
      pegboard )、 ( grip strength measurement ) 、(somatosensory evoked potential, SSEP) at 1 month,
      3 months, and 6 months after treatment.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 19, 2017</start_date>
  <completion_date type="Anticipated">July 30, 2018</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2018</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Neurological function</measure>
    <time_frame>6 months</time_frame>
    <description>Blood biochemical, Neurobehavioral examination (NIH Stroke Scale 16-20)</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">3</enrollment>
  <condition>Stroke</condition>
  <arm_group>
    <arm_group_label>GXNPC1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Three subjects will be to treatment (n=3) groups. The treatment group will receive brain transplants of autologous ADSCs. Treatment group will receive rehabilitation after the transplantation. Subjects will be assessed by magnetic resonance imaging (MRI) and four standardized stroke indices: National Institutes of Health Stroke Scale (NIHSS), European Stroke Scale (ESS), European Stroke Motor Subscale (EMS), Barthel Index, MMSE and Gait analyses at 1 month, 3 months, and 6 months after treatment.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ADSCs</intervention_name>
    <description>Autologous ADSCs</description>
    <arm_group_label>GXNPC1</arm_group_label>
    <other_name>hADSCs</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  stroke investigators with age 65 to 80 years

          -  history of stroke between six months and 10 years

          -  Systolic pressure and Diastolic pressure were maintained under 160 mmHg and 110 mmHg

          -  INR &lt; 2.5, platelets counts 1－5 x 10^5/μl

          -  Damaged area range between 0.5 cm to 6 cm by brain MRI

        Exclusion Criteria:

          -  Pregnant women

          -  Investigators with AIDS, cancer, liver dysfunction

          -  Others can't fit into the trial evaluate by investigator
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hualien T Hospital</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hualien Tzu Chi Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Lin Sh Zong</last_name>
    <phone>+886 3 8561825</phone>
    <email>shinnzong@yahoo.com.tw</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Lin Po Cheng</last_name>
    <phone>+886 3 6585959</phone>
    <phone_ext>332</phone_ext>
    <email>genecold@gwoxi.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Gwo Xi Stem Cell Applied Technology Co., Ltd.</name>
      <address>
        <city>Hsinchu</city>
        <zip>30261</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Huang Pi Chun</last_name>
      <phone>88636585959</phone>
      <phone_ext>332</phone_ext>
      <email>sabrina@gwoxi.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hualien Tzu Chi Hospital</name>
      <address>
        <city>Hualien city</city>
        <zip>97002</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Lin Sh Zone</last_name>
      <phone>+886 3 8561825</phone>
      <email>shinnzong@yahoo.com.tw</email>
    </contact>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 3, 2016</study_first_submitted>
  <study_first_submitted_qc>June 22, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 27, 2016</study_first_posted>
  <last_update_submitted>December 11, 2017</last_update_submitted>
  <last_update_submitted_qc>December 11, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 12, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

